Clinical trial
An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Endemic Regions of Brazil
NCT01751139 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Endemic Regions of Brazil
- Lead sponsor
- GlaxoSmithKline
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 18, 2014
- Completion date
- December 20, 2018
- Enrollment
- 3,300 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.